China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
29.20
+0.29 (1.00%)
Apr 15, 2026, 3:00 PM CST

SHA:600511 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
52,42150,50049,59245,43646,442
Other Revenue
47.5697.79103.9962.9526.26
52,46850,59749,69645,49946,469
Revenue Growth (YoY)
3.70%1.81%9.22%-2.09%15.08%
Cost of Revenue
49,01447,00345,70441,68142,848
Gross Profit
3,4543,5943,9923,8173,621
Selling, General & Admin
1,1901,2671,4301,3921,355
Research & Development
69.3173.7171.26755.75
Other Operating Expenses
134.92126.25109.6946.91120.86
Operating Expenses
1,4281,4891,6201,4981,566
Operating Income
2,0262,1052,3722,3192,055
Interest Expense
-27.17-33.66-31.57-26.88-43.71
Interest & Investment Income
622.87620.95525.32362.42354.09
Currency Exchange Gain (Loss)
-2.871.940.55-1.652.71
Other Non Operating Income (Expenses)
-4.18-7.04-9.23-43.29-18
EBT Excluding Unusual Items
2,6152,6872,8572,6092,350
Gain (Loss) on Sale of Investments
0.07-18.210.82--
Gain (Loss) on Sale of Assets
0.21-0.190.081.68-0.07
Other Unusual Items
-14.76-14.962.8176.995.08
Pretax Income
2,6002,6542,9312,6882,445
Income Tax Expense
510.74523.83596.42559.18516.3
Earnings From Continuing Operations
2,0892,1302,3342,1291,929
Minority Interest in Earnings
-92.81-129.65-188.47-164.65-174.42
Net Income
1,9972,0002,1461,9641,754
Net Income to Common
1,9972,0002,1461,9641,754
Net Income Growth
-0.18%-6.80%9.26%11.97%26.86%
Shares Outstanding (Basic)
755755754755755
Shares Outstanding (Diluted)
755755754755755
Shares Change (YoY)
0.00%0.00%-0.00%-0.00%
EPS (Basic)
2.652.652.842.602.32
EPS (Diluted)
2.652.652.842.602.32
EPS Growth
-0.18%-6.80%9.27%11.97%26.86%
Free Cash Flow
1,9371,5282,5822,2651,862
Free Cash Flow Per Share
2.572.033.423.002.47
Dividend Per Share
0.8000.8000.8540.7820.700
Dividend Growth
--6.32%9.21%11.71%27.27%
Gross Margin
6.58%7.10%8.03%8.39%7.79%
Operating Margin
3.86%4.16%4.77%5.10%4.42%
Profit Margin
3.81%3.95%4.32%4.32%3.77%
Free Cash Flow Margin
3.69%3.02%5.20%4.98%4.01%
EBITDA
2,1442,2232,4852,4232,155
EBITDA Margin
4.09%4.39%5.00%5.32%4.64%
D&A For EBITDA
118.49118.63113.09103.86100.1
EBIT
2,0262,1052,3722,3192,055
EBIT Margin
3.86%4.16%4.77%5.10%4.42%
Effective Tax Rate
19.64%19.74%20.35%20.80%21.12%
Revenue as Reported
52,46850,59749,69645,49946,469
Advertising Expenses
2.914.746.73.252.25
Source: S&P Global Market Intelligence. Standard template. Financial Sources.